11/14/2024
3:53 PM | Benitec Biopharma (Subject)
Nantahala Capital Management, LLC (Filed by)
| Form SCHEDULE 13G | |
11/14/2024
3:32 PM | Benitec Biopharma (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/12/2024
11:15 PM | Benitec Biopharma (Filer)
| Form EFFECT | |
11/07/2024
11:30 AM | Benitec Biopharma (Subject)
FRANKLIN RESOURCES INC (Filed by)
| Form SCHEDULE 13G/A | |
11/06/2024
2:26 PM | Benitec Biopharma (Subject)
JANUS HENDERSON GROUP PLC (Filed by)
| Form SC 13G/A | |
11/01/2024
4:04 PM | Benitec Biopharma (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
10/25/2024
1:19 PM | Benitec Biopharma (Subject)
JANUS HENDERSON GROUP PLC (Filed by)
| Form SC 13G/A | |
|
10/23/2024
8:23 AM | Benitec Biopharma (Filer)
| Form DEF 14A | |
10/22/2024
4:24 PM | Benitec Biopharma (Filer)
| Form DEFA14A | |
10/15/2024
7:07 AM | Benitec Biopharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/15/2024
5:08 AM | Benitec Biopharma (Filer)
| Form 424B5 | |
10/11/2024
4:13 PM | Benitec Biopharma (Filer)
| Form 424B5 | |
10/11/2024
3:52 PM | Benitec Biopharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/11/2024
3:53 PM | Benitec Biopharma (Filer)
| Form PRE 14A | |
10/08/2024
3:45 PM | Benitec Biopharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/01/2024
3:46 PM | Benitec Biopharma (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
09/30/2024
4:17 PM | Averill Madison Master Fund, Ltd. (Reporting)
Averill Master Fund, Ltd. (Reporting)
Benitec Biopharma (Issuer)
Cowen Aaron (Reporting)
SUVRETTA CAPITAL MANAGEMENT, LLC (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/30/2024
4:18 PM | Benitec Biopharma (Subject)
SUVRETTA CAPITAL MANAGEMENT, LLC (Filed by)
| Form SC 13D/A | |
09/26/2024
3:30 PM | Benitec Biopharma (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
09/26/2024
3:43 PM | Benitec Biopharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/29/2024
3:28 PM | Benitec Biopharma (Filer)
| Form DEF 14A | |
07/19/2024
3:59 PM | Benitec Biopharma (Filer)
| Form PRE 14A | |
07/15/2024
4:18 PM | Benitec Biopharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/08/2024
9:22 AM | Benitec Biopharma (Issuer)
Mehta Kishan (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
05/28/2024
11:15 PM | Benitec Biopharma (Filer)
| Form EFFECT | |
05/13/2024
7:01 AM | Benitec Biopharma (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/13/2024
7:05 AM | Benitec Biopharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/02/2024
4:27 PM | Averill Madison Master Fund, Ltd. (Reporting)
Averill Master Fund, Ltd. (Reporting)
Benitec Biopharma (Issuer)
Cowen Aaron (Reporting)
SUVRETTA CAPITAL MANAGEMENT, LLC (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
04/29/2024
10:44 AM | Benitec Biopharma (Subject)
Oliveira Steven Michael (Filed by)
| Form SC 13G | |
04/18/2024
8:45 PM | Benitec Biopharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/18/2024
7:53 AM | Benitec Biopharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/11/2024
11:10 AM | ADAGE CAPITAL PARTNERS GP, L.L.C. (Filed by)
Benitec Biopharma (Subject)
| Form SC 13G/A | |
03/08/2024
3:17 PM | Benitec Biopharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/05/2024
11:15 PM | Benitec Biopharma (Filer)
| Form EFFECT | |
02/26/2024
8:06 AM | Benitec Biopharma (Filer)
| Form DEL AM | |
02/14/2024
5:18 PM | Benitec Biopharma (Subject)
CITADEL ADVISORS LLC (Filed by)
| Form SC 13G/A | |
02/13/2024
7:01 AM | Benitec Biopharma (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
02/13/2024
7:15 AM | Benitec Biopharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/22/2023
7:02 PM | Benitec Biopharma (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
12/11/2023
11:41 AM | Benitec Biopharma (Subject)
FRANKLIN RESOURCES INC (Filed by)
| Form SC 13G/A | |
12/07/2023
6:55 PM | Benitec Biopharma (Issuer)
BUCHI J KEVIN (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
I was wrong. Dead wrong. (Ad) I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was.
Because here we are, a quarter of a century later, almost to the exact day, and it’s happening again.  Here’s the full story for you. |
12/07/2023
6:56 PM | Benitec Biopharma (Issuer)
Francis Peter (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/07/2023
6:57 PM | Benitec Biopharma (Issuer)
Smith Edward F (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/30/2023
6:31 AM | Benitec Biopharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
